My name is Charlie Howden and I have had a dream of paddling the west coast of Costa Rica to raise money for a charity. Who knew that I would be doing it while battling Pancreatic Cancer. I am from Eastbourne, East Sussex in the South East of England and have always been keen in
The Forbeck Foundation is proud to announce that two, 2012 Forbeck Scholars Dr. Kris Sarosiek and Dr. Kris Wood published a collaborative research paper! The Forbeck Foundation brings together top scientists and researchers to collaborate and shorten the cancer research timetable. We are excited when Scholars and Researchers work together after meeting at a Forbeck meeting. Titled:
Dr.Catherine Bollard, Washington Children’s Hospital, Washington, DC Dr. Daniel Powell, University of Pennsylvania, Philadelphia, PA Immunotherapy Some of the most exciting results in cancer medicine, in the last decade, have come about by treating relapsed patients with B cell lymphoma with their own T cells that have been modified to attack the tumor cells.
The Forbeck Foundation is a top supporter of the INRGdb, housed at the University of Chicago. “The Genomic Data Commons has the potential to transform the study of cancer at all scales,” said Robert Grossman, director of the Genomic Data Commons project and professor of medicine at University of Chicago. “It supplies the data so
CHAIRMEN Joan Brugge, Ph.D. Harvard Medical School Boston, MA Jeffrey Engelman MD, Ph.D. Massachusetts General Hospital Boston, MA OVERVIEW Cancer therapies that specifically target the genetic alterations associated with subsets of advanced cancers have shown impressive success in the clinic. Examples include ABL inhibitors fro chronic myelogenous leukemia, RAF inhibitors for BRAF mutant melanomas, EGFR